Literature DB >> 23550645

mir-17-92: a polycistronic oncomir with pleiotropic functions.

Virginie Olive1, Qijing Li, Lin He.   

Abstract

Neoplastic transformation is caused by accumulation of genetic lesions that ultimately convert normal cells into tumor cells with uncontrolled proliferation and survival, unlimited replicative potential, and invasive growth. Emerging evidence has highlighted the functional importance of non-coding RNAs, particularly microRNAs (miRNAs), in the initiation and progression of tumor development. The mir-17-92 miRNA is among the best characterized miRNA oncogenes, whose genomic amplification or aberrant elevation are frequently observed in a variety of tumor types. Unlike protein-coding oncogenes, where one transcript produces one protein, mir-17-92 encodes a polycistronic miRNA transcript that yields six individual miRNA components. This unique gene structure, shared by many important miRNA oncogenes and tumor suppressors, underlies the unique functionality of mir-17-92 in a cell type and context-dependent manner. Recent functional dissection of mir-17-92 indicates that individual mir-17-92 components perform distinct biological functions, which collectively regulate multiple related cellular processes during development and disease. The structural complexity of mir-17-92 as a polycistronic miRNA oncogene, along with the complex mode of interactions among its components, constitutes the molecular basis for its unique functional complexity during normal and tumor development.
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23550645      PMCID: PMC3972423          DOI: 10.1111/imr.12054

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  59 in total

Review 1.  Biogenesis of small RNAs in animals.

Authors:  V Narry Kim; Jinju Han; Mikiko C Siomi
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

2.  TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation.

Authors:  Inha Heo; Chirlmin Joo; Young-Kook Kim; Minju Ha; Mi-Jeong Yoon; Jun Cho; Kyu-Hyeon Yeom; Jinju Han; V Narry Kim
Journal:  Cell       Date:  2009-08-21       Impact factor: 41.582

3.  A dicer-independent miRNA biogenesis pathway that requires Ago catalysis.

Authors:  Sihem Cheloufi; Camila O Dos Santos; Mark M W Chong; Gregory J Hannon
Journal:  Nature       Date:  2010-06-03       Impact factor: 49.962

4.  The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.

Authors:  Piu Wong; Masayuki Iwasaki; Tim C P Somervaille; Francesca Ficara; Christine Carico; Christopher Arnold; Chang-Zheng Chen; Michael L Cleary
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

5.  Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.

Authors:  Konstantinos J Mavrakis; Andrew L Wolfe; Elisa Oricchio; Teresa Palomero; Kim de Keersmaecker; Katherine McJunkin; Johannes Zuber; Taneisha James; Aly A Khan; Christina S Leslie; Joel S Parker; Patrick J Paddison; Wayne Tam; Adolfo Ferrando; Hans-Guido Wendel
Journal:  Nat Cell Biol       Date:  2010-02-28       Impact factor: 28.824

6.  Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.

Authors:  Shuangli Mi; Zejuan Li; Ping Chen; Chunjiang He; Donglin Cao; Abdel Elkahloun; Jun Lu; Luis A Pelloso; Mark Wunderlich; Hao Huang; Roger T Luo; Miao Sun; Miao He; Mary Beth Neilly; Nancy J Zeleznik-Le; Michael J Thirman; James C Mulloy; Paul P Liu; Janet D Rowley; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

7.  miR-19 is a key oncogenic component of mir-17-92.

Authors:  Virginie Olive; Margaux J Bennett; James C Walker; Cong Ma; Iris Jiang; Carlos Cordon-Cardo; Qi-Jing Li; Scott W Lowe; Gregory J Hannon; Lin He
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

8.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Authors:  Ping Mu; Yoon-Chi Han; Doron Betel; Evelyn Yao; Massimo Squatrito; Paul Ogrodowski; Elisa de Stanchina; Aleco D'Andrea; Chris Sander; Andrea Ventura
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

9.  MicroRNA MiR-17 retards tissue growth and represses fibronectin expression.

Authors:  Sze Wan Shan; Daniel Y Lee; Zhaoqun Deng; Tatiana Shatseva; Zina Jeyapalan; William W Du; Yaou Zhang; Jim W Xuan; Siu-Pok Yee; Vinayakumar Siragam; Burton B Yang
Journal:  Nat Cell Biol       Date:  2009-07-26       Impact factor: 28.824

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  74 in total

1.  GVHD and miR: good things in small packages.

Authors:  Jonathan Serody
Journal:  Blood       Date:  2015-09-10       Impact factor: 22.113

Review 2.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

3.  STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma.

Authors:  Elisa Spaccarotella; Elisa Pellegrino; Manuela Ferracin; Cristina Ferreri; Giuditta Cuccuru; Cuiling Liu; Javeed Iqbal; Daniela Cantarella; Riccardo Taulli; Paolo Provero; Ferdinando Di Cunto; Enzo Medico; Massimo Negrini; Wing C Chan; Giorgio Inghirami; Roberto Piva
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

4.  Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.

Authors:  Molykutty J Aryankalayil; Sunita Chopra; Adeola Makinde; Iris Eke; Joel Levin; Uma Shankavaram; Laurel MacMillan; Claire Vanpouille-Box; Sandra Demaria; C Norman Coleman
Journal:  Biomarkers       Date:  2018-06-19       Impact factor: 2.658

Review 5.  MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.

Authors:  K Musilova; M Mraz
Journal:  Leukemia       Date:  2014-12-26       Impact factor: 11.528

6.  A positive feedback loop of SIRT1 and miR17HG promotes the repair of DNA double-stranded breaks.

Authors:  Luoyijun Xie; Ruxiao Huang; Shuang Liu; Weijia Wu; Ailing Su; Runkai Li; Xu Liu; Yiting Lei; Huidi Sun; Xinguang Liu; Shun Xu
Journal:  Cell Cycle       Date:  2019-07-15       Impact factor: 4.534

Review 7.  MicroRNA regulation of F-box proteins and its role in cancer.

Authors:  Zhao-Hui Wu; Lawrence M Pfeffer
Journal:  Semin Cancer Biol       Date:  2015-10-01       Impact factor: 15.707

8.  Combinations of elevated tissue miRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancer.

Authors:  Sujuan Feng; Xiaosong Qian; Han Li; Xiaodong Zhang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

9.  MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.

Authors:  Yongxia Wu; Jessica Heinrichs; David Bastian; Jianing Fu; Hung Nguyen; Steven Schutt; Yuejun Liu; Junfei Jin; Chen Liu; Qi-Jing Li; Changqing Xia; Xue-Zhong Yu
Journal:  Blood       Date:  2015-07-02       Impact factor: 22.113

10.  The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.

Authors:  Steven G Chaulk; Victoria J Lattanzi; Samantha E Hiemer; Richard P Fahlman; Xaralabos Varelas
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.